Stocks
Denali Therapeutics (DNLI) Net margin US GAAP (year values) |
|||||||||
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -740.7% | 21.2% | -597.2% | -300.6% | -43.9% | |||
| Changes by years, y/y, % | -713pp | +762pp | -618pp | +297pp | +257pp | +9.4% | |||
Denali Therapeutics. Net margin, %
Denali Therapeutics. Net margin, changes, pp
Denali Therapeutics (DNLI) Net margin US GAAP (quarter values) |
||||||||
| FY2022Q3 | FY2022Q4 | FY2023Q1 | FY2023Q2 | FY2023Q3 | LTM ? | |||
| Net margin, % | ? | -2 902% | -959.6% | -312.4% | 62.3% | -7 842% | ||
| Changes by years, y/y, % | -1 302pp | -358pp | -158pp | +174pp | -4 939pp | |||
| Changes by quarters, q/q, % | -2 790pp | +1 943pp | +647pp | +375pp | -7 904pp | |||
